Korean J Nephrol.  2002 Mar;21(2):322-326.

Recurrent Rhabdomyolysis after Cerivastatin-Gemfibrozil Combination Therapy

Affiliations
  • 1Department of Internal Medicine, College of Medicine, Sungkyunkwan University, Samsung Medical Center, Masan, Korea. Ksr59@unitel.co.kr
  • 2Department of Rehabilitation Medicine, College of Medicine, Sungkyunkwan University, Samsung Medical Center, Masan, Korea.

Abstract

A 64-year-old woman with ischemic heart disease was admitted to our hospital because of both leg pain and difficulty to walk for 5 days. She had taken cerivastatin and gemfibrozil for atherosclerosis and ischemic heart disease. One year ago, she had been admitted to our hospital because of acute renal failure due to rhabdomyolysis of unknown origin and was improved after conservative therapy. Laboratory studies revealed serum creatinine 1.2 mg/dL, creatine kinase 23,700 IU/L, serum myoglobin >500 ng/mL, urine myoglobin >3,000 ng/mL. (99m)Tc-HDP whole body Bone scan showed multiple increased uptakes of the soft tissue, especially both calf. With supportive care, she was recovered and discharged with normal creatinine(0.8 mg/dL) and creatine kinase(260 IU/L).

Keyword

Rhabdomyolysis; Cerivastatin; Gemfibrozil

MeSH Terms

Acute Kidney Injury
Atherosclerosis
Creatine
Creatine Kinase
Creatinine
Female
Gemfibrozil
Humans
Leg
Middle Aged
Myocardial Ischemia
Myoglobin
Rhabdomyolysis*
Creatine
Creatine Kinase
Creatinine
Gemfibrozil
Myoglobin
Full Text Links
  • KJN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr